Moreover, for four types of cancer (KIRP, UVM, CESC, and LUSC), patients in the high-expression level group for SH2B1 gene experienced a better prognosis than those in the low/medium-expression level group. This evidence concerns the gene SH2B1 and cervical squamous cell carcinoma.